These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24736611)

  • 1. Increased migration of human mesenchymal stromal cells by autocrine motility factor (AMF) resulted in enhanced recruitment towards hepatocellular carcinoma.
    Bayo J; Fiore E; Aquino JB; Malvicini M; Rizzo M; Peixoto E; Andriani O; Alaniz L; Piccioni F; Bolontrade M; Podhajcer O; Garcia MG; Mazzolini G
    PLoS One; 2014; 9(4):e95171. PubMed ID: 24736611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human umbilical cord perivascular cells exhibited enhanced migration capacity towards hepatocellular carcinoma in comparison with bone marrow mesenchymal stromal cells: a role for autocrine motility factor receptor.
    Bayo J; Fiore E; Aquino JB; Malvicini M; Rizzo M; Peixoto E; Alaniz L; Piccioni F; Bolontrade M; Podhajcer O; Garcia MG; Mazzolini G
    Biomed Res Int; 2014; 2014():837420. PubMed ID: 25147818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor promotion through the mesenchymal stem cell compartment in human hepatocellular carcinoma.
    Hernanda PY; Pedroza-Gonzalez A; van der Laan LJ; Bröker ME; Hoogduijn MJ; Ijzermans JN; Bruno MJ; Janssen HL; Peppelenbosch MP; Pan Q
    Carcinogenesis; 2013 Oct; 34(10):2330-40. PubMed ID: 23740837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of AMF/PGI-mediated tumorigenic activities by ursolic acid in cultured hepatoma cells and in a mouse model.
    Shih WL; Yu FL; Chang CD; Liao MH; Wu HY; Lin PY
    Mol Carcinog; 2013 Oct; 52(10):800-12. PubMed ID: 22549898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins.
    Torimura T; Ueno T; Kin M; Harada R; Nakamura T; Kawaguchi T; Harada M; Kumashiro R; Watanabe H; Avraham R; Sata M
    Hepatology; 2001 Jul; 34(1):62-71. PubMed ID: 11431735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified mesenchymal stromal cells by in vitro transcribed mRNA: a therapeutic strategy for hepatocellular carcinoma.
    Cantero MJ; Bueloni B; Gonzalez Llamazares L; Fiore E; Lameroli L; Atorrasagasti C; Mazzolini G; Malvicini M; Bayo J; García MG
    Stem Cell Res Ther; 2024 Jul; 15(1):208. PubMed ID: 38992782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of CCR1 gene overexpression on the migration of bone marrow - derived mesenchymal stem cells towards hepatocellular carcinoma].
    Gao Y; Huang XL; Zhang L; Deng L; Yin AH; Sun BC; Lu S
    Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):354-359. PubMed ID: 28763842
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatocellular carcinoma cell line-microenvironment induced cancer-associated phenotype, genotype and functionality in mesenchymal stem cells.
    Salah RA; Nasr MA; El-Derby AM; Abd Elkodous M; Mohamed RH; El-Ekiaby N; Osama A; Elshenawy SE; Hamad MHM; Magdeldin S; Gabr MM; Abdelaziz AI; El-Badri NS
    Life Sci; 2022 Jan; 288():120168. PubMed ID: 34826437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming.
    Liu Y; Ren H; Zhou Y; Shang L; Zhang Y; Yang F; Shi X
    J Exp Clin Cancer Res; 2019 May; 38(1):228. PubMed ID: 31142342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of hepatoma cells migration by phosphoglucose isomerase/autocrine motility factor through the upregulation of matrix metalloproteinase-3.
    Yu FL; Liao MH; Lee JW; Shih WL
    Biochem Biophys Res Commun; 2004 Jan; 314(1):76-82. PubMed ID: 14715248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem Cells.
    Pelagalli A; Nardelli A; Fontanella R; Zannetti A
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27409610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy.
    Yin Z; Jiang K; Li R; Dong C; Wang L
    Mol Cancer; 2018 Dec; 17(1):178. PubMed ID: 30593276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mesenchymal stem cells versus curcumin on sonic hedgehog signaling in experimental model of Hepatocellular Carcinoma.
    Abdel-Tawab MS; Fouad H; Sedeak AY; Doudar NA; Rateb EE; Faruk E; Reyad HR
    Mol Biol Rep; 2024 Jun; 51(1):740. PubMed ID: 38874802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trafficking mechanism of bone marrow-derived mesenchymal stem cells toward hepatocellular carcinoma HepG2 cells by modulating Endoglin, CXCR4 and TGF-β.
    Mardomi A; Sabzichi M; Hussein Somi M; Shanehbandi D; Rahbarghazi R; Taj Sanjarani O; Samadi N
    Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):81-86. PubMed ID: 27755957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin α5 in hepatocellular carcinoma.
    Chen J; Ji T; Wu D; Jiang S; Zhao J; Lin H; Cai X
    Cell Death Dis; 2019 May; 10(6):425. PubMed ID: 31142737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
    Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
    Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial precursor cells promote angiogenesis in hepatocellular carcinoma.
    Sun XT; Yuan XW; Zhu HT; Deng ZM; Yu DC; Zhou X; Ding YT
    World J Gastroenterol; 2012 Sep; 18(35):4925-33. PubMed ID: 23002366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.